FYI.

This story is over 5 years old.

The VICE Guide to Right Now

Another Company Will Start Offering Martin Shkreli's $750 Pill for a Buck

The internet's most hated dude has been undermined yet again.

Read: Hillary Clinton Wants the US to Launch an Investigation Against Martin Shkreli's Company

Martin Shkreli—unrepentant capitalist, head of Turing Pharmaceuticals, erstwhile unlikely patron of punk, guy who possibly once offered his ex 10 grand to let him go down on her, and the man more commonly known as "the $750 pill guy who is the worst"—has found himself being undermined even further.

Yesterday, Imprimis Pharmaceuticals announced that they'll start offering an alternative to Daraprim, a drug that fights some of the parasitic infections that patients with serious ailments like as cancer and AIDS are particularly susceptible to contracting. The best part? A 100-count bottle will cost patients as little as $99, bringing the average price of the drug from $750 per pill to 99 cents.

Imprimis CEO Mark Baum was quoted in the announcement as saying the drug was developed as a response to Shkreli's price hike, which was criticized by everyone from Hillary Clinton to Donald Trump. "This is not the first time a sole supply generic drug—especially one that has been approved for use as long as Daraprim—has had its price increased suddenly and to a level that may make it unaffordable," Baum added in a statement. The company also has plans to address other instances of price gauging by Big Pharma through the introduction of affordable generics.

Don't read this as strictly a humanitarian move on the part of Imprimis, however—the company said they still plan on making a profit from the drug.

Follow Drew on Twitter.